New developments in osteoimmunology (Q38052462)

27 August 2017

title

New developments in osteoimmunology (English)

1 reference

27 August 2017

Hiroshi Takayanagi

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

16 October 2012

1 reference

Nature Reviews Rheumatology

27 August 2017

published in

1 reference

27 August 2017

volume

8

1 reference

27 August 2017

issue

11

1 reference

27 August 2017

page(s)

684-689

1 reference

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Bone quality--the material and structural basis of bone strength and fragility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Osteoimmunology: interactions of the bone and immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Osteoimmunology: crosstalk between the immune and bone systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Microenvironmental niches in the bone marrow required for B-cell development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Uncertainty in the niches that maintain haematopoietic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Osteoimmunology and the effects of the immune system on bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Therapeutic antibodies for autoimmunity and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Matrix-embedded cells control osteoclast formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

The bone marrow at the crossroads of blood and immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Osteoblastic cells regulate the haematopoietic stem cell niche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Identification of the haematopoietic stem cell niche and control of the niche size

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Strontium can increase some osteoblasts without increasing hematopoietic stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Endothelial and perivascular cells maintain haematopoietic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Osteoclasts support the survival of human plasma cells in vitro.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Emerging MRI methods in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast-enhanced magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Absence of sclerostin adversely affects B-cell survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Osteoclast-osteoblast communication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Suppression of bone formation by osteoclastic expression of semaphorin 4D

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

Osteoprotection by semaphorin 3A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.167

31 March 2020

Identifiers

DOI

10.1038/NRRHEUM.2012.167

1 reference

Dimensions Publication ID

27 August 2017

1015976041

0 references

Fatcat ID

release_sfg6tkoyzzaqdaw6pkxqy7okyu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sfg6tkoyzzaqdaw6pkxqy7okyu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference